[1]
|
余艳萍, 阿布来提•阿不都哈尔. 川崎病诊断与治疗新进展[J]. 中华临床医师杂志(电子版), 2016, 10(4): 566-570.
|
[2]
|
杨晓东, 黄敏. 川崎病诊断实验室指标及其临床价值[J]. 中国实用儿科杂志, 2013, 28(7): 491-494.
|
[3]
|
Agarwal, S. and Agrawal, D.K. (2017) Kawasaki Disease: Etiopatho-Genesis and Novel Treatment Strategies. Expert Review of Clinical Immunology, 13, 247-258. https://doi.org/10.1080/1744666X.2017.1232165
|
[4]
|
谢添. 川崎病的治疗与随访[J]. 国际儿科学杂志, 2017, 44(11): 757-760+764.
|
[5]
|
杨芳, 陈琅, 沈晓丽, 等. N端脑钠肽前体在小儿川崎病诊断中的价值[J]. 临床儿科杂志, 2010, 28(7): 630-632.
|
[6]
|
De Benedictis, F.M., Colaneri, M., Osimani, P. and Bettuzzi, M.G. (2010) Amino-Terminal Pro-B-Type Natriuretic Peptide in Refractory Kawasaki Disease. Pediatric Cardiology, 30, 837-839.
https://doi.org/10.1007/s00246-009-9416-3
|
[7]
|
Japanese Circulation Society Joint Working Group (2010) Guidelines for Diagnosis and Management of Cardiovascular Sequelae in Kawasaki Disease (JCS 2008). Circulation Journal, 74, 1989-2020.
https://doi.org/10.1253/circj.CJ-10-74-0903
|
[8]
|
Kawasaki, T. (1967) Acute Febrile Mucocutaneous Syndrome with Lymphoid Involvement with Specific Desquamation of the Fingers and Toes in Children. Arerugī, 16, 178-222.
|
[9]
|
Kawasaki, T., Kosaki, F., Okawa, S., et al. (1974) A New Infantile Acute Febrile Mucocutaneous Lymph Node Syndrome (MLNS) Prevailing in Japan. Pediatrics, 54, 271-276.
|
[10]
|
Burns, J.C., Wiggins Jr., J.W., Toews, W.H., et al. (1986) Clinical Spectrum of Kawasaki Disease in Infants Younger than 6 Months of Age. The Journal of Pediatrics, 109, 759-763. https://doi.org/10.1016/S0022-3476(86)80689-8
|
[11]
|
O’Loughlin, J.E. (1989) Management of Kawasaki Syndrome: A Con-sensus Statement Prepared by North American Participants of the Third International Kawasaki Disease Symposium, Tokyo, Japan, December, 1988. The Pediatric Infectious, 8, 663-667. https://doi.org/10.1097/00006454-198910000-00001
|
[12]
|
Ayusawa, M., Sonobe, T., Uemura, S., et al. (2005) Revision of Diagnostic Guidelines for Kawasaki Disease (the 5th Revised Edition). The Pediatric Infectious, 47, 232-234. https://doi.org/10.1111/j.1442-200x.2005.02033.x
|
[13]
|
Burns, J.C., Kushner, H.I., Bastian, J.F., Shike, H., Shimizu, C., Matsubara, T. and Turner, C.L. (2000) Kawasaki Disease: A Brief History. Pediatrics, 106, 27-37.
https://doi.org/10.1542/peds.106.2.e27
|
[14]
|
Newburger, J.W., Takahashi, M., Gerber, M.A., et al. (2004) Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation, 110, 2747-2771. https://doi.org/10.1161/01.CIR.0000145143.19711.78
|
[15]
|
McCrindle, B.W., Rowley, A.H., Newburger, J.W., et al. (2017) Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals from the American Heart Association. Circulation, 135, 927-999. https://doi.org/10.1161/CIR.0000000000000484
|
[16]
|
赵晓东, 杜忠东. 川崎病专题讨论会纪要[J]. 中华儿科杂志, 2007, 45(11): 826-830.
|
[17]
|
Moore, A., Harnden, A. and Mayon-White, R. (2014) Recognising Kawasaki Disease in UK Primary Care: A Descriptive Study Using the Clinical Practice Research Datalink. British Journal of General Practice, 64, e477-e483.
https://doi.org/10.3399/bjgp14X680953
|
[18]
|
Boudiaf, H. and Achir, M. (2016) The Clinical Profile of Kawasaki Disease in Algerian Children: A Single Institution Experience. Journal of Tropical Pediatrics, 62, 139-143. https://doi.org/10.1093/tropej/fmv090
|
[19]
|
Rowley, A.H. (2015) The Complexities of the Diagnosis and Management of Ka-wasaki Disease. Infectious Disease Clinics of North America, 29, 525-537. https://doi.org/10.1016/j.idc.2015.05.006
|
[20]
|
Seo, Y.-M., Kang, H.-M., Lee, S.-C., Yu, J.-W., Kil, H.-R., Rhim, J.-W., Han, J.-W. and Lee, K.-Y. (2018) Clinical Implications in La-boratory Parameter Values in Acute Kawasaki Disease for Early Diagnosis and Proper Treatment. Korean Journal of Pediatrics, 61, 160-166. https://doi.org/10.3345/kjp.2018.61.5.160
|
[21]
|
Dahdah, N., Siles, A., Fournier, A., Cousineau, J., Delvin, E., Saint-Cyr, C., Spiegelblatt, L., Bonny, Y., Vartian, M. and Montigny, M. (2009) Natriuretic Peptide as an Adjunctive Diagnostic Test in the Acute Phase of Kawasaki Disease. Pediatric Cardiology, 30, 810-817. https://doi.org/10.1007/s00246-009-9441-2
|
[22]
|
李雪琴, 吕菊红, 李文君. 血浆N端脑利钠肽前体测定在不完全川崎病患儿早期诊断的临床意义[J]. 山西医科大学学报, 2014, 45(3): 227-229.
|
[23]
|
王祥, 陈智, 肖云彬, 等. 血N末端脑利钠肽原和降钙素原在川崎病诊断中的价值[J]. 中国中西医结合儿科学, 2017, 9(4): 301-303.
|
[24]
|
李雪琴, 吕菊红, 李文君. 血浆N末端B型利钠肽原与C反应蛋白在小儿川崎病中的变化及临床意义[J]. 中国临床研究, 2014, 27(5): 583-584.
|
[25]
|
Newburger, J.W., Taubert, K.A., Shulman, S.T., Rowley, A.H., Gewitz, M.H., Takahashi, M. and McCrindle, B.W. (2003) Summary and Abstracts of the Seventh International Kawasaki Disease Symposium: December 4-7, 2001, Hakone, Japan. Pediatric Research, 53, 153-157. https://doi.org/10.1203/00006450-200301000-00026
|
[26]
|
笪小虎, 徐天祥. 川崎病患儿急性期血浆N端脑钠肽前体水平测定的临床意义[J]. 首都医药, 2011(8): 31-32.
|
[27]
|
顾明, 李斌. 动态测定血浆N-端脑利钠肽在川崎病诊治中的应用[J]. 中国实用医药, 2015, 10(27): 114-115.
|
[28]
|
范江花, 段蔚, 罗海燕, 等. 血浆N端脑利钠肽前体和降钙素原对早期川崎病冠状动脉损害的预测价值[J]. 儿科药学杂志, 2018, 24(9): 1-5.
|
[29]
|
Cantinotti, M., Clerico, A., Murzi, M., Vittorini, S. and Emdin, M. (2008) Clinical Relevance of Measurement of Brain Natriuretic Peptide and N-Terminal Pro-Brain Natriuretic Peptide in Pediatric Cardiology. Clinica Chimica Acta, 390, 12-22. https://doi.org/10.1016/j.cca.2007.12.020
|
[30]
|
李璟昊, 王虹, 邢艳琳, 等. 小儿心内膜弹力纤维增生症血浆脑钠肽/N端脑钠肽前体与左室射血分数的相关性研究[J]. 东南大学学报(医学版), 2016, 35(1): 26-31.
|
[31]
|
王轶娜, 杨宇, 陈平, 等. 无创正压通气对慢性阻塞性肺疾病急性加重合并Ⅱ型呼吸衰竭患者血浆N端脑利钠肽前体水平的影响[J]. 中南大学学报(医学版), 2012, 37(4): 325-331.
|
[32]
|
高艺花, I-Seok Kang, Geena Kim. 肺动脉高压患儿血浆N端脑利钠肽前体和右心室Tei指数相关性研究[J]. 中国实用儿科杂志, 2013, 28(7): 525-528.
|